Bibliografia UJ CM

1/4
Angela Bellini, Ulrike Potschger, Virginie Bernard, Eve Lapouble, Sylvain Baulande, Peter F. Ambros, Nathalie Auger, Klaus Beiske, Marie Bernkopf, David R. Betts, Jaydutt Bhalshankar, Nick Bown, Katleen de Preter, Nathalie Clement, Valerie Combaret, Jaime Font de Mora, Sally L. George, Irene Jimenez, Marta Jeison, Barbara Marques, Tommy Martinsson, Katia Mazzocco, Martina Morini, Annick Muhlethaler-Mottet, Rosa Noguera, Gaelle Pierron, Maria Rossing, Sabine Taschner-Mandl, Nadine Van Roy, Ales Vicha, Louis Chesler, Walentyna Balwierz, Victoria Castel, Martin Elliott, Per Kogner, Genevieve Laureys, Roberto Luksch, Josef Malis, Maja Popovic-Beck, Shifra Ash, Olivier Delattre, Dominique Valteau-Couanet, Deborah A. Tweddle, Ruth Ladenstein, Gudrun Schleiermacher.
Frequency and prognostic impact of ALK amplifications and mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1).
Journal of Clinical Oncology
2021 : Vol. 39, nr 30, s. 3377-3390, il., bibliogr. 56 poz., abstr.
Autor korespondencyjny: Gudrun Schleiermacher.
Open Access Creative Commons Attribution License CC-BY 4.0.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
2/4
Alberto Garaventa, Ulrike Poetschger, Dominique Valteau-Couanet, Roberto Luksch, Victoria Castel, Martin Elliott, Shifra Ash, Godfrey C.F. Chan, Genevieve Laureys, Maja Beck-Popovic, Kim Vettenranta, Walentyna Balwierz, Henrik Schroeder, Cormac Owens, Maja Cesen, Vassilios Papadakis, Toby Trahair, Gudrun Schleiermacher, Peter Ambros, Stefania Sorrentino, Andrew D.J. Pearson, Ruth Lydia Ladenstein.
Randomized Trial of Two Induction Therapy Regimens for High-Risk Neuroblastoma : HR-NBL1.5 International Society of Pediatric Oncology European Neuroblastoma Group Study.
Journal of Clinical Oncology
2021 : Vol. 39, nr 23, s. 2552-2563
Autor korespondencyjny: Ruth Lydia Ladenstein.
p-ISSN: 0732-183X
e-ISSN: 1527-7755
AZ
ORG
AIF
IF: 50.739
Adres url:
Streszczenie w PubMed:
3/4
Keith Holmes, Ulrike Potschger, Andrew D.J. Pearson, Sabine Sarnacki, Giovanni Cecchetto, Javier Gomez-Chacon, Roly Squire, Enrique Freud, Adam Bysiek, Lucas E. Matthyssens, Martin Metzelder, Tom Monclair, Jakob Stenman, Michal Rygl, Lars Rasmussen, Jean-Marc Joseph, Sabine Irtan, Stefano Avanzini, Jan Godzinski, Kristin Bjornland, Martin Elliott, Roberto Luksch, Victoria Castel, Shifra Ash, Walentyna Balwierz, Genevieve Laureys, Ellen Ruud, Vassilios Papadakis, Josef Malis, Cormac Owens, Henrik Schroeder, Maja Beck-Popovic, Toby Trahair, Ana Forjaz De Lacerda, Peter F. Ambros, Mark N. Gaze, Kieran McHugh, Dominique Valteau-Couanet, Ruth Lydia Ladenstein.
Influence of Surgical Excision on the Survival of Patients With Stage 4 High-Risk Neuroblastoma : A Report From the HR-NBL1/SIOPEN Study.
Journal of Clinical Oncology
2020 : Vol. 38, nr 25, s. 2902-2915
Autor korespondencyjny: Ruth Lydia Ladenstein.
p-ISSN: 0732-183X
AZ
ORG
AIF
IF: 44.544
Adres url:
Streszczenie w PubMed:
DOI:
4/4
Ruth Ladenstein, Ulrike Poetschger, Martin Elliott, Roberto Luksch, Victoria Castel, Isaac Yaniv, Vassilios Papadakis, Genevieve Laureys, Josef Malis, Walentyna Balwierz, Ellen Ruud, Per Kogner, Henrik Schroeder, Ana Forjaz De Lacerda, Maja Beck Popovic, Pavel Bician, Miklos Garami, Toby Trahair, Andrew D.J. Pearson, Dominique Valteau Couanet.
Prognostic factors in stage 4 neuroblastoma treated with busulphan-melphalan: Report from the European HR-NBIA/Siopen trial.
Journal of Clinical Oncology
2016 : Vol. 34, nr 15 suppl., abstr. 10527.
2016 ASCO Annual Meeting, Chicago, 3-7 June 2016.
p-ISSN: 0732-183X
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ